中华皮肤科杂志 ›› 2019, Vol. 52 ›› Issue (10): 747-752.doi: 10.35541/cjd.20190136

• 论著 • 上一篇    下一篇

他克莫司对人角质形成细胞蛋白酶活化受体2表达及功能的影响

王上上    倪春雅    邹颖    李巍    徐金华   

  1. 复旦大学附属华山医院皮肤科,上海  200040
  • 收稿日期:2018-12-19 修回日期:2019-05-30 发布日期:2019-09-30
  • 通讯作者: 徐金华 E-mail:jhxuhuashan@126.com

Effect of tacrolimus on the expression and function of protease-activated receptor 2 in human keratinocytes

Wang Shangshang, Ni Chunya, Zou Ying, Li Wei, Xu Jinhua   

  1. Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China
  • Received:2018-12-19 Revised:2019-05-30 Published:2019-09-30
  • Contact: Xu Jinhua E-mail:jhxuhuashan@126.com

摘要: 【摘要】 目的 研究他克莫司对体外培养的人角质形成细胞蛋白酶活化受体2(PAR-2)表达及功能的影响。方法 10-9~10-5 mol/L他克莫司与人角质形成细胞共培养24 h后,采用半定量反转录-聚合酶链反应、免疫荧光和Western印迹分别检测人角质形成细胞PAR-2 mRNA和蛋白表达水平的变化,应用Fluo-4钙荧光探针检测不同浓度他克莫司对人角质形成细胞激活PAR-2后引起的细胞内钙离子浓度变化的影响,以不加他克莫司处理组为对照组。采用单因素方差分析比较各组人角质形成细胞PAR-2表达和细胞内钙离子浓度,LSD-t检验进行两两比较。结果 PAR-2在角质形成细胞的胞膜和胞质表达。角质形成细胞与10-9~10-5 mol/L他克莫司共培养24 h后,PAR-2 mRNA的表达水平与对照组比较均显著降低(均P < 0.05),且与他克莫司浓度呈负相关(r = -0.962,P = 0.009)。免疫荧光和Western印迹显示,与对照组比较,10-5和10-6 mol/L他克莫司组PAR-2蛋白表达水平显著降低(均P < 0.05),10-7 mol/L他克莫司组PAR-2蛋白表达水平亦降低(免疫荧光法P < 0.05;Western印迹法P > 0.05),但10-8和10-9 mol/L他克莫司组PAR-2表达水平变化无统计学意义(均P > 0.05)。共培养24 h后,10-5、10-6和10-7 mol/L他克莫司组PAR-2激活后细胞内钙离子峰浓度(峰值吸光度分别为1 463 ± 283、1 455 ± 270、1 423 ± 291)较对照组(1 602 ± 407)显著降低(t值分别为2.582、2.821、2.923,P值分别为0.032、0.022、0.019),10-8和10-9 mol/L他克莫司组(分别为1 649 ± 379、1 633 ± 415)变化无统计学意义(t值分别为0.846、0.462,P值分别为0.422、0.657)。结论 他克莫司可抑制人角质形成细胞PAR-2的表达,并抑制PAR-2激动剂所引起的钙离子动员。

关键词: 他罗利姆; 角蛋白细胞; 钙信号; 受体, 凝血酶; 受体, PAR-2

Abstract: 【Abstract】 Objective To evaluate the in vitro effect of tacrolimus on the expression and function of protease-activated receptor 2 (PAR-2) in cultured human keratinocytes. Methods After 24-hour co-culture of human keratinocytes with 10-9 - 10-5 mol/L tacrolimus, semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR)was performed to determine the mRNA expression of PAR-2, immunofluorescence(IF)staining and Western blot analysis were performed to determine the protein expression of PAR-2 in the keratinocytes, and the fluorescent calcium probe fluo-4 was used to evaluate the effect of tacrolimus at different concentrations on the intracellular calcium concentration after the activation of PAR-2 in the keratinocytes. The group treated without tacrolimus served as control group. One-way analysis of variance was used to compare the PAR-2 expression and calcium concentration in the human keratinocytes in different groups, and least significant difference (LSD)-t test was carried out for multiple comparisons. Results PAR-2 was expressed on both the membrane and cytoplasm of keratinocytes. After 24-hour co-culture of keratinocytes with 10-9 - 10-5 mol/L tacrolimus, the PAR-2 mRNA expression significantly decreased in these cells compared with the control group (all P < 0.05), and was negatively correlated with the tacrolimus concentration (r = -0.962, P = 0.009). IF staining and Western blot analysis showed that the PAR-2 protein expression was significantly lower in the 10-5- and 10-6-mol/L tacrolimus groups than in the control group (both P < 0.05), and decreased to a certain extent in the 10-7-mol/L tacrolimus group (IF staining: P < 0.05; Western blot analysis: P > 0.05). No significant difference in the PAR-2 protein expression was observed between the 10-8- or 10-9-mol/L tacrolimus group and the control group (both P > 0.05). After 24-hour co-culture, the peak concentration of intracellular calcium after PAR-2 activation was significantly lower in the 10-5-, 10-6- and 10-7-mol/L tacrolimus groups (peak absorbance: 1 463 ± 283, 1 455 ± 270, 1 423 ± 291 respectively) than in the control group (1 602 ± 407; t = 2.582, 2.821, 2.923, P = 0.032, 0.022, 0.019, respectively), while there was no significant difference between the 10-8- or 10-9-mol/L tacrolimus group (1 649 ± 379, 1 633 ± 415 respectively) and the control group (t = 0.846, 0.462, P = 0.422, 0.657, respectively). Conclusion Tacrolimus can inhibit PAR-2 expression and suppress calcium mobilization induced by a PAR-2 agonist in keratinocytes.

Key words: Tacrolimus, Keratinocytes, Calcium signaling, Receptors, thrombin, Receptor, PAR-2

引用本文

王上上 倪春雅 邹颖 李巍 徐金华. 他克莫司对人角质形成细胞蛋白酶活化受体2表达及功能的影响[J]. 中华皮肤科杂志, 2019,52(10):747-752. doi:10.35541/cjd.20190136

Wang Shangshang, Ni Chunya, Zou Ying, Li Wei, Xu Jinhua. Effect of tacrolimus on the expression and function of protease-activated receptor 2 in human keratinocytes[J]. Chinese Journal of Dermatology, 2019, 52(10): 747-752.doi:10.35541/cjd.20190136